Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Moore

Showing results (81-90 of 354) with videos related to

Pageof 36
Sort By:
Drug Safety|June 13, 2020
Does Ibuprofen Worsen COVID-19?Nicholas Moore, Bruce Carleton, Patrick Blin, et al.
Investigative Ophthalmology & Visual Science|September 28, 2006
Estimating the yearly number of eyes with treatable neovascular age-related macular degeneration using a direct standardization method and a markov modelJean-François Korobelnik, Nicholas Moore, Patrick Blin, et al.
Pharmacoepidemiology and Drug Safety|September 30, 2003
Benzodiazepine utilization patterns in Alzheimer's disease patientsRajaa Lagnaoui, Nicholas Moore, Yola Moride, et al.
The American Journal of Medicine|January 21, 2019
Real-Life Benefits of Statins for Cardiovascular Prevention in Elderly Subjects: A Population-Based Cohort StudyJulien Bezin, Nicholas Moore, Yohann Mansiaux, et al.
Archives of Internal Medicine|May 30, 2012
Factors associated with serious traffic crashes: a prospective study in southwest FranceSylvie Blazejewski, Pierre-Olivier Girodet, Ludivine Orriols, et al.
Pharmacoepidemiology and Drug Safety|June 7, 2007
The European sertindole safety and exposure survey: a follow-up study of 8600 patientsJoseph Peuskens, Nicholas Moore, Jean-Michel Azorin, et al.
Therapie|November 28, 2018
Pharmacoepidemiology of non-steroidal anti-inflammatory drugsNicholas Moore, Mai Duong, Sinem Ezgi Gulmez, et al.
Pharmacoepidemiology and Drug Safety|May 6, 2020
Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemicAnton Pottegård, Xavier Kurz, Nicholas Moore, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|October 19, 2010
Anti-inflammatory, immunomodulatory, and heme oxygenase-1 inhibitory activities of ravan napas, a formulation of uighur traditional medicine, in a rat model of allergic asthmaSajida Abdureyim, Nurmuhammat Amat, Anwar Umar, et al.
Journal of Sleep Research|February 24, 2006
Nocturnal sustained attention during sleep deprivation can be predicted by specific periods of subjective daytime alertness in normal young humansJacques Taillard, Nicholas Moore, Bruno Claustrat, et al.
Pageof 36

Showing results (81-90 of 354) with videos related to

Sort By:
Pageof 36
Drug Safety|June 13, 2020
Does Ibuprofen Worsen COVID-19?Nicholas Moore, Bruce Carleton, Patrick Blin, et al.
Investigative Ophthalmology & Visual Science|September 28, 2006
Estimating the yearly number of eyes with treatable neovascular age-related macular degeneration using a direct standardization method and a markov modelJean-François Korobelnik, Nicholas Moore, Patrick Blin, et al.
Pharmacoepidemiology and Drug Safety|September 30, 2003
Benzodiazepine utilization patterns in Alzheimer's disease patientsRajaa Lagnaoui, Nicholas Moore, Yola Moride, et al.
The American Journal of Medicine|January 21, 2019
Real-Life Benefits of Statins for Cardiovascular Prevention in Elderly Subjects: A Population-Based Cohort StudyJulien Bezin, Nicholas Moore, Yohann Mansiaux, et al.
Archives of Internal Medicine|May 30, 2012
Factors associated with serious traffic crashes: a prospective study in southwest FranceSylvie Blazejewski, Pierre-Olivier Girodet, Ludivine Orriols, et al.
Pharmacoepidemiology and Drug Safety|June 7, 2007
The European sertindole safety and exposure survey: a follow-up study of 8600 patientsJoseph Peuskens, Nicholas Moore, Jean-Michel Azorin, et al.
Therapie|November 28, 2018
Pharmacoepidemiology of non-steroidal anti-inflammatory drugsNicholas Moore, Mai Duong, Sinem Ezgi Gulmez, et al.
Pharmacoepidemiology and Drug Safety|May 6, 2020
Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemicAnton Pottegård, Xavier Kurz, Nicholas Moore, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|October 19, 2010
Anti-inflammatory, immunomodulatory, and heme oxygenase-1 inhibitory activities of ravan napas, a formulation of uighur traditional medicine, in a rat model of allergic asthmaSajida Abdureyim, Nurmuhammat Amat, Anwar Umar, et al.
Journal of Sleep Research|February 24, 2006
Nocturnal sustained attention during sleep deprivation can be predicted by specific periods of subjective daytime alertness in normal young humansJacques Taillard, Nicholas Moore, Bruno Claustrat, et al.
Pageof 36